Ahrens Investment Partners’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Ahrens Investment Partners’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$17.8K	Buy	+82	New	+$16K	0.01%	489

Other funds holding SWAV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ahrens Investment Partners's SWAV Position: Q1 2023 in Review

Ahrens Investment Partners opened a new position in Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2023: 82 shares worth $17.8K. The stake represents 0.01% of the portfolio and ranks #489 among its holdings.

381 funds tracked by Wall St. Rank hold SWAV as of Q1 2023.

Ahrens Investment Partners held 82 shares of Shockwave Medical, Inc. Common Stock worth $17.8K as of Q1 2023.
Shockwave Medical, Inc. Common Stock was a new Ahrens Investment Partners position in Q1 2023.
Shockwave Medical, Inc. Common Stock made up 0.01% of Ahrens Investment Partners's portfolio in Q1 2023, its #489 holding.
381 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2023.

Based on Ahrens Investment Partners's 13F filing for Q1 2023, filed 24 Apr 2023.